SUPN - SUPERNUS PHARMACEUTICALS, INC.
53.87
-0.400 -0.743%
Share volume: 643,456
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$54.27
-0.40
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-06-2024 | 11-04-2024 | 02-25-2025 | 05-06-2025 | 08-05-2025 | 11-06-2025 | 03-02-2026 | |
| Assets | |||||||||
| Total Assets | 1.304 B | 1.316 B | 1.343 B | 1.368 B | 1.347 B | 1.382 B | 1.420 B | 1.453 B | |
| Current Assets | 544.321 M | 591.002 M | 640.003 M | 686.070 M | 687.584 M | 738.866 M | 593.891 M | 644.182 M | |
| Inventories | 75.079 M | 68.155 M | 63.981 M | 54.293 M | 49.423 M | 44.023 M | 79.399 M | 82.385 M | |
| Other Current Assets | 23.772 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 23.772 M | 295.098 M | 371.537 M | 384.281 M | 347.742 M | 377.885 M | 129.789 M | 180.222 M | |
| Total Receivables | 147.734 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 297.736 M | 52.089 M | 31.673 M | 69.331 M | 115.848 M | 144.711 M | 151.371 M | 128.448 M | |
| Total Non-current Assets | 759.769 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 12.969 M | 12.274 M | 11.876 M | 11.545 M | 11.338 M | 11.069 M | 10.627 M | 10.531 M | |
| Other Assets | 38.367 M | 712.553 M | 690.822 M | 670.458 M | 648.368 M | 632.470 M | 815.236 M | 797.935 M | |
| Intangible Assets | 579.752 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 117.019 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.304 B | 1.316 B | 1.343 B | 1.368 B | 1.347 B | 1.382 B | 1.420 B | 1.453 B | |
| Total liabilities | 374.924 M | 358.375 M | 335.551 M | 332.340 M | 316.585 M | 318.505 M | 370.087 M | 390.934 M | |
| Total current liabilities | 314.554 M | 308.656 M | 291.508 M | 292.397 M | 281.772 M | 286.360 M | 330.629 M | 338.171 M | |
| Accounts Payable | 14.397 M | 82.611 M | 75.803 M | 76.352 M | 76.891 M | 77.739 M | 108.613 M | 107.800 M | |
| Other liabilities | 7.875 M | 38.279 M | 36.679 M | 34.982 M | 33.832 M | 32.145 M | 39.458 M | 52.763 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 7.875 M | 38.279 M | 36.679 M | 34.982 M | 33.832 M | 32.145 M | 39.458 M | 52.763 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 929.166 M | 957.454 M | 1.007 B | 1.036 B | 1.031 B | 1.064 B | 1.050 B | 1.062 B | |
| Common stock | 54.802 M | 455.225 M | 465.974 M | 479.496 M | 486.265 M | 497.002 M | 527.757 M | 543.882 M | |
| Retained earnings | 482.685 M | 502.601 M | 541.098 M | 556.426 M | 544.599 M | 567.098 M | 521.981 M | 517.876 M |